News and Press Releases

TekniPlex Hires Rahul Goturi as Chief Information Officer

Executive-level move coincides with retirement of longtime CIO Jeff Rishel Goturi brings more than 15 years of CIO experience at global organisations 4 October 2023 -- Ohio, US -- TekniPlex,...

Category: Manufacturing and Packing
Posted: October 4, 2023

Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer

4 October 2023 -- Hillerød, Denmark -- FUJIFILM Diosynth Biotechnologies president and CEO Lars Petersen today announced a new strategic leadership appointment to support the company through its next growth...

Category: Biotechnology
Posted: October 4, 2023

Biotek Allé 1 3400 Hillerød, Denmark

Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19

mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccines Company to begin phase 3 trial of mRNA-1083 in adults...

Category: Clinical Trials, Drug Discovery
Posted: October 4, 2023

Global Headquarters 200 Technology Square Cambridge, MA 02139

Evonetix places first DNA synthesis development platform at Imperial College London

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialisation 4 October 2023 -- Cambridge, UK -- EVONETIX,...

Category: Drug Discovery
Posted: October 4, 2023

9a Coldham’s Business Park, Norman Way Cambridge CB1 3LH

Vertex Presents Positive, Updated VX-880 Results From Ongoing phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting

All patients treated with VX-880 in Parts A and B have follow-up data beyond Day 90 and have demonstrated islet cell engraftment and glucose-responsive insulin production All patients showed improvement...

Category: Clinical Trials
Posted: October 4, 2023

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Sponsored PhD student will join Professor Ed Tate’s group at Imperial College London, UK, in the EPSRC Centre for Doctoral Training in Chemical Biology Project aims to develop the next...

Category: Biotechnology, Drug Discovery
Posted: October 4, 2023

University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation

Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...

Category: Biotechnology
Posted: October 4, 2023

Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR


3 October 2023 – Kaiseraugst, Switzerland – Following the merger of two iconic companies – DSM and Firmenich – in May 2023, dsm-firmenich will make its debut at CPHI Barcelona...

Category: BioManufacturing, Pharmaceutical
Posted: October 4, 2023

Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions 3 October 2023 – Cambridge, UK, and Porto, Portugal –...

Category: BioManufacturing, Biotechnology, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: October 4, 2023

The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom

DIOSynVax and Ethris Publish Preclinical Proof of Concept for Their Broadly Protective Vaccine Technologies in Nature Biomedical Engineering

Successful vaccine candidate combining DIOSynVax's computational multi-virus vaccine antigen payload technology and Ethris’ proprietary non-immunogenic messenger RNA (SNIM mRNA) and lipidoid nanoparticle (SNaP LNP) platforms Data demonstrates broad in vivo...

Category: BioManufacturing, Biotechnology
Posted: October 4, 2023

Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organisations

3 October 2023 -- Philadelphia, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the launch of Signant Biotech – an integrated clinical research...

Category: Clinical Trials
Posted: October 4, 2023

4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462

Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

21 September 2023 – Dublin, Ireland – PRNewswire ‒ Jazz Pharmaceuticals today announced that the European Commission (EC) has granted marketing authorization for Enrylaze (JZP458; a recombinant Erwinia asparaginase or...

Posted: October 3, 2023

Waterloo Exchange, Waterloo Road, Dublin 4

GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564

Collaboration sets stage for GigaGen’s first oncology asset to enter clinical development GIGA-564 is a differentiated anti-CTLA4 antibody with potential to enhance anti-tumor activity and mitigate immune-related toxicities associated with...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 3, 2023

AscellaHealth Named 2023 Best Global Specialty Pharmacy & Healthcare Services Organisation

AscellaHealth wins Global Specialty Pharmacy & Healthcare Services Organisation 2023 following development of its market-leading pharmaceutical financial programme, Pharma FlexFund. Global healthcare and business consulting services provider, AscellaHealth, has been...

Category: Pharmaceutical
Posted: October 3, 2023

AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US

Mogrify extends Series A financing to $46m USD

Additional close of $10m USD brings total raised in Series A to $46m USD Funding co-led by Astellas Venture Management and Parkwalk Advisors with participation from other internal investors. Funding...

Posted: October 3, 2023

25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW